Literature DB >> 3353608

Aspects of the use of relative risk models in the design and analysis of cohort studies and prevention trials.

R L Prentice1, S G Self.   

Abstract

Relative risk regression methods provide a unifying and powerful approach to a range of problems in the design and analysis of cohort studies and prevention trials. Standard partial likelihood-based estimation procedures do not, however, encompass several features that are important in such contexts. Specifically, one may wish to relate disease rates marginally to 'recent' risk factor measurements, whereas a partial likelihood approach requires one to condition on an accumulating risk factor history. Secondly, risk factor values may be ascertained with considerable measurement error, thereby requiring specialized procedures to estimate relative risk parameters. Thirdly, analysis of raw materials to obtain desired covariate (risk factor) histories may involve considerable expense if carried out for the entire cohort. Case-control and case-cohort sampling procedures can avoid much of this expense, but once again partial likelihood estimation procedures require generalization. Such generalizations are described herein.

Mesh:

Year:  1988        PMID: 3353608     DOI: 10.1002/sim.4780070127

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  8 in total

1.  First report on genome wide association study in western Indian population reveals host genetic factors for COVID-19 severity and outcome.

Authors:  Ramesh Pandit; Indra Singh; Afzal Ansari; Janvi Raval; Zarna Patel; Raghav Dixit; Pranay Shah; Kamlesh Upadhyay; Naresh Chauhan; Kairavi Desai; Meenakshi Shah; Bhavesh Modi; Madhvi Joshi; Chaitanya Joshi
Journal:  Genomics       Date:  2022-06-06       Impact factor: 4.310

2.  Global DNA methylation and one-carbon metabolism gene polymorphisms and the risk of breast cancer in the Sister Study.

Authors:  Lisa A Deroo; Sophia C E Bolick; Zongli Xu; David M Umbach; David Shore; Clarice R Weinberg; Dale P Sandler; Jack A Taylor
Journal:  Carcinogenesis       Date:  2013-10-15       Impact factor: 4.944

3.  Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology.

Authors:  C Wittenbecher; R Cuadrat; L Johnston; F Eichelmann; S Jäger; O Kuxhaus; M Prada; F Del Greco M; A A Hicks; P Hoffman; J Krumsiek; F B Hu; M B Schulze
Journal:  Nat Commun       Date:  2022-02-17       Impact factor: 17.694

4.  Major bleeding during oral anticoagulant therapy associated with factor V activation by factor Xa.

Authors:  Anja Maag; Nienke van Rein; Tim J Schuijt; Wil F Kopatz; Danielle Kruijswijk; Stella Thomassen; Tilman M Hackeng; Rodney M Camire; Tom van der Poll; Joost C M Meijers; Mettine H A Bos; Cornelis van 't Veer
Journal:  J Thromb Haemost       Date:  2021-11-23       Impact factor: 16.036

5.  Metals and Breast Cancer Risk: A Prospective Study Using Toenail Biomarkers.

Authors:  Nicole M Niehoff; Katie M O'Brien; Alexander P Keil; Keith E Levine; Chamindu Liyanapatirana; Laura G Haines; Suramya Waidyanatha; Clarice R Weinberg; Alexandra J White
Journal:  Am J Epidemiol       Date:  2021-11-02       Impact factor: 4.897

6.  Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factors.

Authors:  Clemens Wittenbecher; Olga Kuxhaus; Heiner Boeing; Norbert Stefan; Matthias B Schulze
Journal:  Diabetologia       Date:  2019-09-09       Impact factor: 10.122

Review 7.  Biomarkers of Vascular Injury and Type 2 Diabetes: A Prospective Study, Systematic Review and Meta-Analysis.

Authors:  Laura Pletsch-Borba; Cora Watzinger; Renée Turzanski Fortner; Verena Katzke; Lukas Schwingshackl; Solomon A Sowah; Anika Hüsing; Theron Johnson; Marie-Luise Groß; Sandra González Maldonado; Michael Hoffmeister; Peter Bugert; Rudolf Kaaks; Mirja Grafetstätter; Tilman Kühn
Journal:  J Clin Med       Date:  2019-11-27       Impact factor: 4.241

8.  Conducting Real-world Evidence Studies on the Clinical Outcomes of Diabetes Treatments.

Authors:  Sebastian Schneeweiss; Elisabetta Patorno
Journal:  Endocr Rev       Date:  2021-09-28       Impact factor: 19.871

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.